Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
about
Phage cocktails and the future of phage therapyCharacterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7Bacteriophages as antimicrobial agents against major pathogens in swine: a reviewA Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial OrganismsPhage-host interplay: examples from tailed phages and Gram-negative bacterial pathogens.Bacteriophage therapy against Enterobacteriaceae.Use of encapsulated bacteriophages to enhance farm to fork food safety.Delivering phage therapy per os: benefits and barriers.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.Enhancement of chicken macrophage cytokine response to Salmonella Typhimurium when combined with bacteriophage P22.Salmonella Typhimurium-specific bacteriophage ΦSH19 and the origins of species specificity in the Vi01-like phage familyFeed withdrawal and transportation effects on Salmonella enterica levels in market-weight pigs.Physiological and Molecular Characterization of Salmonella Bacteriophages Previously Used in Phage Therapy.Microencapsulation with alginate/CaCO3: A strategy for improved phage therapy.Bacteriophage cocktail and multi-strain probiotics in the feed for weanling pigs: effects on intestine morphology and targeted intestinal coliforms and Clostridium.The impact of orally administered phages on host immune response and surrounding microbial communities.Two-stage, self-cycling process for the production of bacteriophages.Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release.Bacteriophages and their role in food safety.Effect of bacteriophage supplementation on the growth performance, nutrient digestibility, blood characteristics, and fecal microbial shedding in growing pigsMeat Science and Muscle Biology Symposium: Development of bacteriophage treatments to reduce Escherichia coli O157:H7 contamination of beef products and produce.Complete Genome Sequences of Two Escherichia coli O157:H7 Phages Effective in Limiting Contamination of Food Products.Genome sequence of a salmonella phage used to control salmonella transmission in Swine.Bacteriophages as twenty-first century antibacterial tools for food and medicine.Long tail fibres of the novel broad-host-range T-even bacteriophage S16 specifically recognize Salmonella OmpC.Bacteriophage use to control Salmonella biofilm on surfaces present in chicken slaughterhouses.Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells.Identification and biosynthesis of thymidine hypermodifications in the genomic DNA of widespread bacterial viruses.Framing the Future with Bacteriophages in Agriculture.Evaluation of the broad-spectrum lytic capability of bacteriophage cocktails against various Salmonella serovars and their effects on weaned pigs infected with Salmonella Typhimurium.
P2860
Q26995797-77DA84DE-EEC5-4023-92BB-6726C9B246D0Q28395425-28AEE4CB-1248-4215-90C7-EAA8BCF2377CQ35994120-0AF7D0CA-EA0C-4278-9A25-14F0A5EAC8D6Q37727839-30CDD16E-371E-4B8E-BA89-A7C5063BB8E4Q38246271-54A353A5-A180-4A2B-8D00-AA7256F866D2Q38348303-0FCD17FF-6C33-4D34-931B-4A1119B74965Q38584325-89A3269A-FB48-4AB7-A7EB-1EE24DD31F90Q39019401-C6B7AC17-E0D2-4A7F-ADD8-FBD102A84F65Q39029801-6BE0109E-B4AE-44D8-9F92-39F2D612C916Q39226018-2A0FDAE3-DBC0-4EBE-9270-E6D61EA929C9Q39250617-6B976EF6-5215-439C-B7BE-C55342E55725Q40126672-CE9A5AB5-5D02-424D-AD7E-83DE60B0261CQ40267322-204B8502-61BB-4081-B09B-D560679E33F6Q40358982-ADB8EC63-1FFD-4E0A-95B2-88E62D88A920Q40677621-AD44926E-AF4A-4056-BABE-45486ACF73C9Q41385038-BA6F034C-CDBD-4133-AAB4-5334BC1C3651Q41671442-D6A9D488-0290-4DBD-9F48-B77AC0DB6D93Q41918244-418251F2-6C64-486B-8FCA-AFB999B6DC95Q42029552-EB86C629-08AD-4D5A-BA61-37B0F95A5235Q42148758-5025F582-6806-4E98-9CCA-C3F80E82AF16Q42239335-6BE5B074-7D9A-4620-A70C-19D03142D492Q42874048-EE204790-4005-40A5-A1FD-F61B85DF082BQ42874053-87BEDEE7-0D6A-4935-89B5-FC6C2CE7F2DBQ43031037-7C8AAFAF-2649-45E8-9C39-11A913015ED5Q45236112-46F8A494-7DEB-4394-A880-A6B6DE6A1494Q49949840-E85EFF13-1D09-4CD2-8911-88FE2F52502CQ50041908-C1CD5917-57FB-4B4C-BA78-84951FC2F3F8Q52639383-4D1E86BA-DE76-4960-B230-556B66EF2D53Q52648006-B6EFB8BC-B96E-4BDC-896E-EA3A61A28C9DQ55036003-591DCFF8-C461-468D-BC54-E84A4C1014BFQ55453577-12BAF25D-885F-4E8F-8C5C-1453DD4E3A74
P2860
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
@ast
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
@en
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine.
@nl
type
label
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
@ast
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
@en
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine.
@nl
prefLabel
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
@ast
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
@en
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine.
@nl
P2093
P2860
P356
P1476
Phage therapy to reduce preprocessing Salmonella infections in market-weight swine
@en
P2093
Jiayi Zhang
Marcos H Rostagno
Paul D Ebner
P2860
P356
10.1128/AEM.00785-09
P407
P577
2009-10-23T00:00:00Z